PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) Sees Large Drop in Short Interest

PharmaTher Holdings Ltd. (OTCMKTS:PHRRF) was the target of a significant drop in short interest in May. As of May 29th, there was short interest totaling 8,311 shares, a drop of 83.9% from the May 14th total of 51,769 shares. Based on an average daily volume of 266,185 shares, the days-to-cover ratio is currently 0.0 days.

PharmaTher Price Performance

PHRRF stock traded down $0.00 during midday trading on Friday, reaching $0.04. The company had a trading volume of 94,000 shares, compared to its average volume of 175,821. The firm has a 50-day moving average price of $0.05 and a 200-day moving average price of $0.06. PharmaTher has a 1 year low of $0.04 and a 1 year high of $0.55.

PharmaTher Company Profile

PharmaTher Holdings Ltd., a specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes. The company's product pipeline includes KETARX, a hydrochloride injection for the treatment of Parkinson's disease, Amyotrophic Lateral Sclerosis, complex regional pain and Rett syndrome, and anesthesia and procedural sedation, as well as Ischemia reperfusion injury. It also develops KETARX, a microneedle patch, for mental health, neurological, and pain disorders; and KETARX On-body pump for the maintenance of general anesthesia for diagnostic and surgical procedures.